Arena 3 for 3 as Crohn’s drug meets proof-of-concept test

Arena Pharma says its cannabinoid receptor-targeting drug olorinab could help treat the pain associated with Crohn’s disease, one of the most debilitating symptoms of the inflammatory bowel disorder.